PacBio to Report Q1 2026 Earnings on May 7

The genomics company will host a conference call to discuss its first quarter 2026 financial results.

Apr. 16, 2026 at 8:42pm

Got story updates? Submit your updates here. ›

A close-up, cinematic view of intricate, heavy machinery and mechanical components in shades of steel gray, bronze, and black, representing the advanced sequencing technology and infrastructure that powers PacBio's genomics solutions.PacBio's quarterly earnings call provides a window into the complex, high-tech machinery powering the company's genomics innovations.Menlo Park Today

PacBio, a leading life science technology company, announced that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and available on the company's investor relations website.

Why it matters

As a major player in the genomics and sequencing industry, PacBio's quarterly earnings calls provide insights into the company's financial performance and the broader trends in the life sciences technology sector. Investors and industry analysts closely follow these updates to assess PacBio's market position and growth prospects.

The details

PacBio designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The company's products and technologies, including its HiFi long-read sequencing, address a wide range of research applications such as human germline sequencing, plant and animal sciences, infectious disease, oncology, and other emerging areas.

  • The quarterly conference call will be held on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).

The players

PacBio

A premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching PacBio's Q1 2026 earnings call for updates on the company's financial performance, product development, and market trends.

The takeaway

PacBio's quarterly earnings calls provide valuable insights into the genomics and life sciences technology industry, as the company's financial and operational results reflect the broader trends and challenges facing the sector.